So What’s the Deal with ICHRA?
The number of US employees offered ICHRAs continues to grow. Yet, headwinds – including competition, individual coverage market uncertainty, and complexity – may hamper the ICHRA opportunity.
John Syme
John Syme is currently an MBA Intern at OCA Ventures on the Healthcare Team. OCA Ventures is a Chicago-based VC investing in Seed and Series A technology and healthcare companies. The OCA Healthcare team invests in companies across the spectrum of diagnostics, digital health, and healthcare IT. Prior to OCA, John co-founded and led a VC-backed oncology digital health company named Primum. He is currently pursuing his MBA at Northwestern Kellogg School of Management and is based in Evanston, IL.